Shell-Free Copper Indium Sulfide Quantum Dots Induce Toxicity <i>in Vitro</i> and <i>in Vivo</i>.

Abstract

Semiconductor quantum dots (QDs) are attractive fluorescent contrast agents for <i>in vivo</i> imaging due to their superior photophysical properties, but traditional QDs comprise toxic materials such as cadmium or lead. Copper indium sulfide (CuInS₂, CIS) QDs have been posited as a nontoxic and potentially clinically translatable alternative; however, previous <i>in vivo</i> studies utilized particles with a passivating zinc sulfide (ZnS) shell, limiting direct evidence of the biocompatibility of the underlying CIS. For the first time, we assess the biodistribution and toxicity of unshelled CIS and partially zinc-alloyed CISZ QDs in a murine model. We show that bare CIS QDs breakdown quickly, inducing significant toxicity as seen in organ weight, blood chemistry, and histology. CISZ demonstrates significant, but lower, toxicity compared to bare CIS, while our measurements of core/shell CIS/ZnS are consistent with literature reports of general biocompatibility. <i>In vitro</i> cytotoxicity is dose-dependent on the amount of metal released due to particle degradation, linking degradation to toxicity. These results challenge the assumption that removing heavy metals necessarily reduces toxicity: indeed, we find comparable <i>in vitro</i> cytotoxicity between CIS and CdSe QDs, while CIS caused severe toxicity <i>in vivo</i> compared to CdSe. In addition to highlighting the complexity of nanotoxicity and the differences between the <i>in vitro</i> and <i>in vivo</i> outcomes, these unexpected results serve as a reminder of the importance of assessing the biocompatibility of core QDs absent the protective ZnS shell when making specific claims of compositional biocompatibility.